In the article titled “Osteoporosis, Fractures, and Diabetes” [1], there was an error regarding the FRAX® tool, which should be clarified as follows:
The article notes: “To partially answer this problem the current osteoporosis classification criteria drafted by the World Health Organization (WHO) are currently revised to include clinical risk factors (http://www.shef.ac.uk/FRAX/)” and “Recently, the fracture risk assessment (FRAX) algorithm has been developed by the WHO, which could assess the fracture risk of an individual even if BMD is not measured [109].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX® tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.